Nat Simons Baxter International Inc Transaction History

Meritage Group LP

  • $3.77 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$74.57 - $87.19 $193,434 - $226,170
-2,594 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$73.77 - $83.61 $191,359 - $216,884
2,594 New
2,594 $209,000
Q1 2021

May 14, 2021
SELL
$76.38 - $86.03 $201,414 - $226,861
-2,637 Closed
0 $0
Q4 2020

Feb 12, 2021
SELL
$75.39 - $82.36 $81,044 - $88,537
-1,075 Reduced 28.96%
2,637 $212,000
Q3 2020

Nov 13, 2020
BUY
$78.33 - $90.73 $290,760 - $336,789
3,712 New
3,712 $299,000

Others Institutions Holding BAX

# of Institutions
1,006
Shares Held
451M
Call Options Held
2.79M
Put Options Held
2.44M
View Full List

About BAXTER INTERNATIONAL INC

BAX Quotes by TradingView
  • Ticker BAX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 504,120,992
  • Market Cap $16.7B
  • Description
  • Baxter International Inc., through its subsidiaries, develops and provides a portfolio of healthcare products worldwide. The company offers peritoneal dialysis and hemodialysis, and additional dialysis therapies and services; intravenous therapies, infusion pumps, administration sets, and drug reconstitution devices; remixed and oncology drug pl...
More about BAX
Track Nat Simons's Portfolio

Track Nat Simons Portfolio

Follow Nat Simons (Meritage Group LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meritage Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Meritage Group LP and Nat Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email